Invo Fertility earnings were -$7.5M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest IVF earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$1.6M, down 27.4% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, IVF reported annual earnings of -$8.0M, with -26.2% growth.
On IVF's earnings call on Invalid Date, Invo Fertility (NASDAQ: IVF) reported Q3 2024 earnings per share (EPS) of -$5.04, up 40% year over year. Total IVF earnings for the quarter were -$1.63 million. In the same quarter last year, Invo Fertility's earnings per share (EPS) was -$8.40.
As of the last Invo Fertility earnings report, Invo Fertility is currently losing money. Invo Fertility's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$7.47 million, a 15.21% decrease year over year.
What was IVF's earnings growth in the past year?
As of Invo Fertility's earnings date in Invalid Date, Invo Fertility's earnings has grown year over year. IVF earnings in the past year totalled -$7.47 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.